From “analogy and comparison” to “hypothesis-deduction”: scientific research training for postgraduates

doi:10.3969/j.issn.2096-045X.2023.03.012

Abstract

Abstract: The theoretical system of traditional Chinese medicine (TCM) comes from the “analogy and comparison”, a premise for putting forward the “hypothesis”, but it lacks the process of inference, deduction and verification. During treatment of major and emerging infectious diseases, problems such as unclear explanation of the scientific mechanism of treating diseases and lack of means for efficacy evaluation, which greatly restricts the role of TCM in the prevention and treatment of infectious diseases and its influence in the world academic field. Focusing on the main problems in the research field and personnel training of TCM lemology, this paper analyzes the complementary characteristics and logical relationship between the “analogy and comparison” of TCM and the “hypothesis-deduction” of modern medicine, and takes as an example that confirming the effectiveness of the concept of “preventing and reversing disease, treating before presence of symptoms” of TCM in the treatment of COVID-19, discusses how to enlighten the academic postgraduates of TCM lemology in scientific research.

Key words: postgraduate education, TCM lemology, analogy and comparison, hypothesis-deduction, COVID-19

CLC Number:

R18
G643.2

Feng Ying, Wang Xianbo. From “analogy and comparison” to “hypothesis-deduction”: scientific research training for postgraduates[J]. Medical Education Management, 2023, 9(3): 338-343.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: https://journal06.magtechjournal.com/Jwk3_yyyzlt/EN/10.3969/j.issn.2096-045X.2023.03.012

https://journal06.magtechjournal.com/Jwk3_yyyzlt/EN/Y2023/V9/I3/338

References

［1］丁邦晗，刘云涛，张忠德，等. 加快完善中医传染病防治体系建设［J］. 中国中医急症， 2021， 30（4）： 568-569， 574.
［2］王永炎，王燕平，于智敏. 循法守度，援物比类［J］. 天津中医药， 2013， 30（8）： 449-450.
［3］彭伟，卢洪洲，卜建宏，等. 中医药治疗甲型流行性感冒研究进展［J］. 中华中医药杂志， 2021， 36（2）： 960-963.
［4］谷晓红，于河，司庆阳. 传染性非典型肺炎中医学研究状况分析［J］. 北京中医药大学学报， 2005， 28（5）： 83-85.
［5］ Xia K Y， Zhao Z Y， Shah T， et al. Composition， clinical efficiency， and mechanism of NHC-approved “three Chinese medicines and three Chinese recipes” for COVID-19 treatment［J］. Front Pharmacol， 2022， 12： 781090.
［6］ Liu J Y， Jiang Y Y， Liu Y， et al. Yindan Jiedu Granules，a traditional Chinese medicinal formulation，as a potential treatment for coronavirus disease 2019［J］. Front Pharmacol， 2021， 11： 634266.
［7］传承精华守正创新——《中共中央国务院关于促进中医药传承创新发展的意见》四大看点［J］. 中华医学信息导报， 2019， 34（21）： 2.
［8］徐国成. 中医药创新型人才培养目标新探［J］. 长春中医药大学学报， 2008， 24（4）： 465.
［9］中华医学会急诊医学分会. “六神丸（胶囊）” 急性感染性疾病临床应用急诊专家共识［J］. 中华急诊医学杂志， 2022， 31（2）： 168-172.
［10］孟宪泽，崔健. 援物比类思维方法在中西医学中的应用［C］//首届中医思维科学学术研讨会论文集，北京：中华中医药学会， 2008： 165-170.
［11］银子涵，孙铭声，徐桂兴，等. 2014～2018年WHO ICTRP针灸临床试验注册情况分析［J］. 中国循证医学杂志， 2019， 19（12）： 1395-1399.
［12］孙永才. 假说演绎法在高中生物教学中的应用［J］. 神州， 2020（7）： 212.
［13］涂向阳. 爱因斯坦的探索性演绎法浅析［J］. 漯河职业技术学院学报， 2012， 11（3）： 75-77.
［14］王宪波，刘景院，王晓静，等. 新型冠状病毒肺炎诊治实践与体会［J］. 北京中医药， 2020， 39（2）： 109-111.
［15］贝润浦. 论姜春华 “截断扭转” 与 “先证而治” 的辨证思想［J］. 北京中医药， 2010， 29（8）： 586-589.
［16］刘景院，向攀，熊号峰，等. 首都医科大学附属北京地坛医院首例重型新型冠状病毒肺炎患者的中西医结合诊治过程［J］. 首都医科大学学报， 2020， 41（3）： 350-353.
［17］ Feng Y， Zhu B B， Liu Y， et al. Yindan Jiedu granules exhibit anti-inflammatory effect in patients with novel coronavirus disease （COVID-19） by suppressing the NF-κB signaling pathway［J］. Phytomedicine， 2022， 95： 153784.
［18］ Cheng S C， Huang W C， JH S P， et al. Quercetin inhibits the production of IL-1β-induced inflamm-atory cytokines and chemokines in ARPE-19 cells via the MAPK and NF-κB signaling pathways［J］. Int J Mol Sci， 2019， 20（12）： 2957.
［19］ Hariharan A， Hakeem A R， Radhakrishnan S， et al. The role and therapeutic potential of NF-kappa-B pathway in severe COVID-19 patients［J］. Inflammopharmacology， 2021， 29（1）： 91-100.
［20］ Kircheis R， Haasbach E， Lueftenegger D， et al. NF-κB pathway as a potential target for treatment of critical stage COVID-19 patients［J］. Front Immunol， 2020， 11： 598444.
［21］隋阳，张聪，初银珠，等. 青壮年新型冠状病毒肺炎并发肺动脉栓塞1例［J］. 中国急救医学， 2020， 40（9）： 907-908.
［22］孙爱华，周碧蓉. 小剂量氯吡格雷联合丹皮酚抗血小板聚集研究［J］. 安徽医科大学学报， 2014， 49（6）： 777-779， 784.
［23］张欢，何丽丽. 牡丹皮、赤芍配伍对活血化瘀疗效及有效成分的影响［J］. 中国现代医学杂志， 2019， 29（7）： 13-17.
［24］栾瑞玲，陆丛笑. 脉络宁注射液的临床应用及不良反应［J］. 医药导报， 2001， 20（1）： 60.

[1]	Ke Xiaohua, Mei Heng. Cultivation problems and countermeasures of professional doctors in clinical medicine in the post epidemic era [J]. Medical Education Management, 2022, 8(5): 531-535.
[2]	Zhang Bin, Liu Ying, Li Shuang. Mental health service needs and educational countermeasures of medical students during COVID-19——Based on undergraduates and junior college students of Capital Medical University [J]. Medical Education Management, 2020, 6(4): 373-377.